Catalio Capital Management
About Catalio Capital Management
Catalio Capital Management is a Venture capital investments in breakthrough biomedical technology companies.
Investment focus
Stages
Sectors
Portfolio (8 in our database)
Personal Genome DiagnosticsPersonal Genome Diagnostics develops a patient-specific analysis of the cancer genome by using advanced tools and technologies.Acquired · $245M raisedPaigeA Global Leader in Digital DiagnosticsSeries C · $220M raisedCambrian BiopharmaCambrian is a distributed development company building therapeutics to lengthen health span.Series C · $160M raisedCelsius TherapeuticsCelsius Therapeutics is a biotechnology company that develops precision medicines for cancer and autoimmune disease patients.Series B · $148M raisedSherlock BiosciencesSherlock Biosciences is an engineering biology company offering unparalleled breadth and versatility for diagnostic solutions.Series B · $136M raisedSatellite BioSatellite Bio specializes in cell therapy, regenerative medicine, synthetic biology, cell biology, and tissue engineering.Series A · $101M raisedXilisXilis is an oncology and precision health company that provides technologies to diagnoses cancer.Series A · $73M raisedEntosEntos uses machine learning-technology for energy and force evaluations required for R&D labs.Series A · $53M raised